Global Tuberculosis Programme News Today

Shobha shukla, bobby ramakant– cnscontd from previous issuewhat works really well in the global north may not work well in the south. health technologies conceived, designed, and manufactured in the global north, and funded mostly by the global nort

It is not natural disasters (like hurricanes or storms) which block access to TB care services most times, but manmade barriers that fuel injustices, inequities, greed, and risk factors that put people at risk of TB disease and death. Since these ...

The World Health Organization (WHO) is organizing a series of in-person meetings, events and symposia in Paris around the 53rd Union World Conference on Lung Health in collaboration with partners and civil society. Here are some highlights of confirmed events.Please watch this space; additional events will be announced.11 November 2023: WHO and Unitaid consultation: transforming the TB response by driving affordable, accessible solutions to reach the most vulnerableVenue: Hyatt Regency Paris E...

Seven and a half million new infections were diagnosed in 2022 – the highest ever recorded by the UN agency

The WHO guidance and e-course on TB and mental health conditions will be launched during a special online webinar which will be held on 3 November 2023, from 12.00-13.30 CET. RegisterWorldwide, almost 1 billion people are living with a mental health condition. People affected by TB have a higher risk of mental health conditions, which can negatively impact TB treatment outcomes, health-related quality of life and other health and social outcomes. In fact, mental health conditions are one of t...

WHO is releasing new guidance on engagement of communities and civil society to end tuberculosis (TB) which aims to strengthen collaboration and leverage capacities of communities and civil society in line with the End TB Strategy. The guidance emphasizes the complementarity of health systems and community systems and the key roles that people affected by TB should play in planning, decision-making, implementation, and monitoring of the TB response.To mark the launch of this guidance, WHO is ...

This document provides methodology and guidance for economists preforming cost-benefit analyses in the health sector.

The Stop TB Partnership’s Global Drug Facility (GDF) today announced price reductions up to 55% for bedaquiline, a critical drug used to treat drug-resistant TB (DR-TB).

News and Press Release in English on World about Health; published on 5 Jun 2023 by WHO

Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.